|
|
||||||||||||||
|
|
|||||||||||||||
RESPIRATORY PHYSIOLOGY |
1 Service dExplorations Fonctionnelles, CHU Cochin, AP-HP-Université, Paris, France
2 Service de Pneumologie, CHU Cochin, AP-HP-Université, Paris, France
3 CeRBEP, Institut Pasteur, Paris, France
4 Laboratoire de Biochimie et Génétique Moléculaires, CHU Cochin, AP-HP-Université, Paris, France
Correspondence to:
Correspondence to:
Dr I Fajac
Service dExplorations Fonctionnelles, Hôpital Cochin, 27 rue du St Jacques, 75014 Paris, France; ifajac{at}cochin.univ-paris5.fr
Background: This study was conducted to determine whether the major nasal airway ion transport abnormalities in cystic fibrosis (that is, defective cAMP regulated chloride secretion and basal sodium hyperabsorption) are related to the clinical expression of cystic fibrosis and/or to the genotype.
Methods: Nasal potential difference was measured in 79 adult patients with cystic fibrosis for whom clinical status, respiratory function, and CFTR genotype were determined.
Results: In univariate and multivariate analysis, patients with pancreatic insufficiency were more likely to have low responses to low chloride (odds ratio (OR) 8.6 (95% CI 1.3 to 58.5), p = 0.03) and isoproterenol (OR 11.2 (95% CI 1.3 to 93.9), p = 0.03) solutions. Similarly, in univariate and multivariate analysis, patients with poor respiratory function (forced expiratory volume in 1 second <50% of predicted value) were more likely to have an enhanced response to amiloride solution (OR 3.7 (95% CI 1.3 to 11.0), p = 0.02). However, there was no significant relationship between nasal potential difference and the severity of the genotype.
Conclusions: Nasal epithelial ion transport in cystic fibrosis is linked to the clinical expression of the disease. The pancreatic status appears to be mostly related to the defect in epithelial chloride secretion whereas the respiratory status is mostly related to abnormal sodium transport and the regulatory function of the CFTR protein.
Keywords: nasal potential difference; cystic fibrosis; ion transport; genotype/phenotype
This article has been cited by other articles:
![]() |
S. M. Rowe, F. Accurso, and J. P. Clancy Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Myerburg, M. B. Butterworth, E. E. McKenna, K. W. Peters, R. A. Frizzell, T. R. Kleyman, and J. M. Pilewski Airway Surface Liquid Volume Regulates ENaC by Altering the Serine Protease-Protease Inhibitor Balance: A MECHANISM FOR SODIUM HYPERABSORPTION IN CYSTIC FIBROSIS J. Biol. Chem., September 22, 2006; 281(38): 27942 - 27949. [Abstract] [Full Text] [PDF] |
||||
![]() |
P G Noone and K W Southern Unravelling salt transport in cystic fibrosis Thorax, November 1, 2004; 59(11): 916 - 917. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |